KPTI - Karyopharm Therapeutics misses by $0.23 misses on revenue May, 09 2019 07:10 AM Karyopharm Therapeutics Inc. Karyopharm Therapeutics (NASDAQ:KPTI): Q1 GAAP EPS of -$1.09 misses by $0.23.More news on: Karyopharm Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...